CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
14920-92-4 | | 1,1,3,3,3-pentamethyl-1-phenyl-disiloxane | C11H20OSi2 | 224.45 | | |
14920-93-5 | | 1,1,3-trimethyl-1,3,3-triphenyl-disiloxane | C21H24OSi2 | 348.59 | | |
14920-94-6 | | 1,1-dimethyl-1,3,3,3-tetraphenyl-disiloxane | C26H26OSi2 | 410.66 | | |
14920-95-7 | | methyl-pentaphenyl-disiloxane | C31H28OSi2 | 472.72 | | |
149200-16-8 | | delayed early response protein 2 | | | | |
149200-34-0 | | amyloid precursor-like protein | | | | |
1492009-34-3 | | (2-methyl-4-propylthiazol-5-yl)methanol | | | | |
149201-79-6 | | (S)-benzyl piperidine-2-carboxylate hcl | | | | |
149204-93-3 | | n-fmoc-n'-methyl-l-asparagine | | | | |
1492042-51-9 | | (z)-isoquinolin-5(4ah)-one oxime | | | | |
149206-55-3 | | 7-ethyl-2'-deoxyguanosine-3'-monophosphate | | | | |
149206-56-4 | | 1-phenyl-2,3-dihydro-1h-pyrrole | | | | |
149206-93-9 | | s-(2-amidinoethyl)thiophosphate | | | | |
149209-47-2 | 2-[2-(三氟甲基)苯氧基]四氢吡喃 | 2-[2-(trifluoromethyl)phenoxy]tetrahydro-2h-pyrane | | | | |
149209-48-3 | 2-碘-6-(三氟甲基)苯酚 | 2-iodo-6-(trifluoromethyl)phenol | | | | |
14921-33-6 | | n-o-nitrophenylsulfenyl-l-threonine*dcha | C10H12N2O5S.C12H23N | 453.59 | | |
14921-35-8 | | N-[(4-methoxyphenyl)methylene]-4-propoxybenzenamine | C17H19NO2 | 269.34 | | |
14921-36-9 | | N-[(4-ethoxyphenyl)methylene]-4-propoxybenzenamine | C18H21NO2 | 283.36 | | |
14921-37-0 | | benzenamine,4-propoxy-N-[(4-propoxyphenyl)methylene]- | C19H23NO2 | 297.39 | | |
14921-38-1 | | N-[[4-(penyloxy)phenyl]methylene]-4-propoxybenzenamine | C21H27NO2 | 325.44 | | |
14921-39-2 | | N-[[4-(hexyloxy)phenyl]methylene]-4-propoxybenzenamine | C22H29NO2 | 339.47 | | |
14921-40-5 | | N-[[4-(heptyloxy)phenyl]methylene]-4-propoxybenenamine | C23H31NO2 | 353.50 | | |
14921-46-1 | | benzenamine,4-butoxy-N-[(4-methoxyphenyl)methylene]- | C18H21NO2 | 283.36 | | |
14921-47-2 | | benzenamine,4-butoxy-N-[(4-ethoxyphenyl)methylene]- | C19H23NO2 | 297.39 | | |
14921-48-3 | | benzenamine,4-butoxy-N-[(4-propoxyphenyl)methylene]- | C20H25NO2 | 311.42 | | |
14921-50-7 | | benzenamine,4-butoxy-N-[[4-(pentyloxy)phenyl]methylene]- | C22H29NO2 | 339.47 | | |
14921-51-8 | | benzenamine,4-butoxy-N-[[4-(hexyloxy)phenyl]methylene]- | C23H31NO2 | 353.50 | | |
14921-52-9 | | benzenamine,4-butoxy-N-[[4-(heptyloxy)phenyl]methylene]- | C24H33NO2 | 367.52 | | |
14921-71-2 | | 4-(((4-ethoxyphenyl)methylene)amino)-benzoic aci | | | | |
149213-65-0 | 四(五氟苯基)硼酸钠 | sodium tetrakis(pentafluorophenyl)borate | | | | |
1492148-75-0 | | 5-bromo-1-(2-fluorobenzyl)pyridin-2(1h)-one | | | | |
149217-76-5 | | n-boc-n-methyl-(R)-3-cyclohexylalanine | | | | |
14922-36-2 | | 4-nitrophenylglyoxylic acid | C8H5NO5 | 195.13 | | |
14922-91-9 | 5-溴-2-乙基苯胺 | 5-bromo-2-ethylaniline | | | | |
149221-05-6 | | methyl 4-(benzylamino)-6-methyl-2-oxocyclohex-3-en-1-oate | | | | |
149221-14-7 | | 3-cyclohexene-1-carboxylic acid, 4-((5-chloro-2-pyridinyl)amino)-6-methyl-2-oxo | | | | |
149221-20-5 | | 4-((4-chlorophenyl)amino)-6-methyl-2-oxo-3-cyclohexene-1-carboxylic aci eth | | | | |
149221-21-6 | | 4-((4-bromophenyl)amino)-6-methyl-2-oxo-3-cyclohexene-1-carboxylic aci ethy | | | | |
149221-23-8 | | 6-methyl-4-((4-methylphenyl)amino)-2-oxo-3-cyclohexene-1-carboxylic aci eth | | | | |
149221-28-3 | | 3-cyclohexene-1-carboxylic acid, 4-((4-(1,1-dimethylethyl)phenyl)amino)-6-methy | | | | |
149221-29-4 | | 3-cyclohexene-1-carboxylic acid, 6-methyl-2-oxo-4-((4-(trifluoromethyl)phenyl)a | | | | |
149221-38-5 | | 3-{[4-(trifluoromethyl)phenyl]amino}cyclohex-2-en-1-one | | | | |
149222-15-1 | 沙丁胺醇ep杂质n | salbutamol ep impurity n | | | | |
149223-66-5 | | sko1 protein | | | | |
149223-81-4 | | hippocalcin | | | | |
149224-00-0 | | prg1 protein | | | | |
149228-22-8 | | methyl-13c ether | C2H6O | 46.06 | | |
1492280-72-4 | 1-[(1,4-二氮杂环庚-1-基)甲基]环戊烷-1-醇 | 1-[(1,4-diazepan-1-yl)methyl]cyclopentan-1-ol | | | | |
14923-04-7 | | 10-ethanoanthracene, 9,10-dihydro-11-((2-diethylaminoethoxy)methyl)- cyclohe | | | | |
14923-17-2 | | 1,1'-tetramethylenedi-guanidin sulfate (1:1) | C6H16N6.H2SO4 | 270.30 | | |